These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 3873989)
1. Folate analogues as substrates of mammalian folylpolyglutamate synthetase. Schoo MM; Pristupa ZB; Vickers PJ; Scrimgeour KG Cancer Res; 1985 Jul; 45(7):3034-41. PubMed ID: 3873989 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of human liver folylpolyglutamate synthetase by non-gamma-glutamylatable antifolate analogs. Clarke L; Rosowsky A; Waxman DJ Mol Pharmacol; 1987 Jan; 31(1):122-7. PubMed ID: 3807889 [TBL] [Abstract][Full Text] [Related]
3. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action. Rumberger BG; Barrueco JR; Sirotnak FM Cancer Res; 1990 Aug; 50(15):4639-43. PubMed ID: 2369741 [TBL] [Abstract][Full Text] [Related]
4. Folate analog nonsubstrates and inhibitors of folylpolyglutamate synthetase as potential cancer chemotherapy drugs. McGuire JJ; Piper JR; Coward JK; Galivan J NCI Monogr; 1987; (5):139-44. PubMed ID: 2448652 [TBL] [Abstract][Full Text] [Related]
5. Role of folylpolyglutamate synthetase in the regulation of methotrexate polyglutamate formation in H35 hepatoma cells. Johnson TB; Nair MG; Galivan J Cancer Res; 1988 May; 48(9):2426-31. PubMed ID: 2451560 [TBL] [Abstract][Full Text] [Related]
6. Human liver folylpolyglutamate synthetase: biochemical characterization and interactions with folates and folate antagonists. Clarke L; Waxman DJ Arch Biochem Biophys; 1987 Aug; 256(2):585-96. PubMed ID: 3619447 [TBL] [Abstract][Full Text] [Related]
7. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells. Rhee MS; Galivan J; Wright JE; Rosowsky A Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264 [TBL] [Abstract][Full Text] [Related]
8. Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetase. Moran RG; Colman PD; Rosowsky A; Forsch RA; Chan KK Mol Pharmacol; 1985 Jan; 27(1):156-66. PubMed ID: 3838105 [TBL] [Abstract][Full Text] [Related]
9. Biosynthesis of polyglutamates of folates. Scrimgeour KG Biochem Cell Biol; 1986 Jul; 64(7):667-74. PubMed ID: 3756000 [TBL] [Abstract][Full Text] [Related]
10. Potent inhibition of human folylpolyglutamate synthetase by suramin. McGuire JJ; Haile WH Arch Biochem Biophys; 1996 Nov; 335(1):139-44. PubMed ID: 8914844 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biologic activity of new side-chain-altered methotrexate and aminopterin analogs with dual inhibitory action against dihydrofolate reductase and folylpolyglutamate synthetase. Rosowsky A; Moran RG; Freisheim JH; Bader H; Forsch RA; Solan VC NCI Monogr; 1987; (5):145-52. PubMed ID: 3431589 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice. Kuehl M; Brixner DI; Broom AD; Avery TL; Blakley RL Cancer Res; 1988 Mar; 48(6):1481-8. PubMed ID: 2449950 [TBL] [Abstract][Full Text] [Related]
13. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity. Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626 [TBL] [Abstract][Full Text] [Related]
14. Structural requirements for the activity of antifolates as substrates for mammalian folylpolyglutamate synthetase. Moran RG; Colman PD; Rosowsky A NCI Monogr; 1987; (5):133-8. PubMed ID: 2448651 [TBL] [Abstract][Full Text] [Related]
15. Effects of folylpolyglutamate synthetase modulation on chemosensitivity of colon cancer cells to 5-fluorouracil and methotrexate. Sohn KJ; Smirnakis F; Moskovitz DN; Novakovic P; Yates Z; Lucock M; Croxford R; Kim YI Gut; 2004 Dec; 53(12):1825-31. PubMed ID: 15542523 [TBL] [Abstract][Full Text] [Related]
16. Methotrexate analogues. 26. Inhibition of dihydrofolate reductase and folylpolyglutamate synthetase activity and in vitro tumor cell growth by methotrexate and aminopterin analogues containing a basic amino acid side chain. Rosowsky A; Freisheim JH; Moran RG; Solan VC; Bader H; Wright JE; Radike-Smith M J Med Chem; 1986 May; 29(5):655-60. PubMed ID: 2871191 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of DL-4,4-difluoroglutamic acid and DL-gamma,gamma-difluoromethotrexate. Tsukamoto T; Kitazume T; McGuire JJ; Coward JK J Med Chem; 1996 Jan; 39(1):66-72. PubMed ID: 8568828 [TBL] [Abstract][Full Text] [Related]
18. Methotrexate analogues. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids. Rosowsky A; Bader H; Kohler W; Freisheim JH; Moran RG J Med Chem; 1988 Jul; 31(7):1338-44. PubMed ID: 2898531 [TBL] [Abstract][Full Text] [Related]
19. Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis. Mendelsohn LG; Shih C; Chen VJ; Habeck LL; Gates SB; Shackelford KA Semin Oncol; 1999 Apr; 26(2 Suppl 6):42-7. PubMed ID: 10598554 [TBL] [Abstract][Full Text] [Related]
20. Novel 6,5-fused ring heterocyclic antifolates: biochemical and biological characterization. McGuire JJ; Bergoltz VV; Heitzman KJ; Haile WH; Russell CA; Bolanowska WE; Kotake Y; Haneda T; Nomura H Cancer Res; 1994 May; 54(10):2673-9. PubMed ID: 8168096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]